DK1569694T3 - Polyaminkonjugater med sure retinoider og fremstilling heraf - Google Patents

Polyaminkonjugater med sure retinoider og fremstilling heraf

Info

Publication number
DK1569694T3
DK1569694T3 DK02758661.9T DK02758661T DK1569694T3 DK 1569694 T3 DK1569694 T3 DK 1569694T3 DK 02758661 T DK02758661 T DK 02758661T DK 1569694 T3 DK1569694 T3 DK 1569694T3
Authority
DK
Denmark
Prior art keywords
preparation
polyamine conjugates
gamma
derivatives
retinoids
Prior art date
Application number
DK02758661.9T
Other languages
English (en)
Inventor
Dionysios Papaioannou
Dionysios Drainas
Original Assignee
Biomedica Life Sciences S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Life Sciences S A filed Critical Biomedica Life Sciences S A
Application granted granted Critical
Publication of DK1569694T3 publication Critical patent/DK1569694T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02758661.9T 2002-08-22 2002-08-22 Polyaminkonjugater med sure retinoider og fremstilling heraf DK1569694T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02758661A EP1569694B1 (en) 2002-08-22 2002-08-22 Polyamine conjugates with acidic retinoids and preparation thereof
PCT/GR2002/000045 WO2004018001A1 (en) 2002-08-22 2002-08-22 Polyamine conjugates with acidic retinoids and preparation thereof

Publications (1)

Publication Number Publication Date
DK1569694T3 true DK1569694T3 (da) 2010-03-29

Family

ID=31898327

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758661.9T DK1569694T3 (da) 2002-08-22 2002-08-22 Polyaminkonjugater med sure retinoider og fremstilling heraf

Country Status (10)

Country Link
US (1) US7517913B2 (da)
EP (1) EP1569694B1 (da)
AT (1) ATE449613T1 (da)
AU (1) AU2002324242A1 (da)
CY (1) CY1110285T1 (da)
DE (1) DE60234542D1 (da)
DK (1) DK1569694T3 (da)
ES (1) ES2336772T3 (da)
PT (1) PT1569694E (da)
WO (1) WO2004018001A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018001A1 (en) 2002-08-22 2004-03-04 Dionysios Papaioannou Polyamine conjugates with acidic retinoids and preparation thereof
US9072778B2 (en) 2005-12-20 2015-07-07 University Of Hawaii Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors
US20080312174A1 (en) * 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
CA2698812A1 (en) * 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
US20100221328A1 (en) * 2008-12-31 2010-09-02 Wertz Christian F Sustained-release formulations
DE102011080131A1 (de) 2011-07-29 2013-01-31 Evonik Degussa Gmbh Niedermolekulare Produkte, und deren Verwendung als reversible oder permanente Niedertemperatur-Vernetzer bei Diels-Alder-Reaktionen
CN102603555B (zh) * 2012-03-22 2014-04-16 浙江大学 一种全反式维甲酸酰胺衍生物及其制备方法和应用
JP2015221830A (ja) * 2015-08-26 2015-12-10 チョンシー ユー 非常に高い皮膚浸透率を有するレチノイド及びレチノイド様化合物の正に荷電した水溶性プロドラッグ
GR1009980B (el) * 2020-03-10 2021-04-22 Πανεπιστημιο Πατρων Κρυσταλλικες μορφες αλατων της ν1-ν12-δι(all-trans-ρετινοϋλο)σπερμινης, διεργασιες για την παραγωγη τους, και φαρμακευτικες συνθεσεις αυτων

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702310D0 (en) * 1997-02-05 1997-03-26 Univ Hertfordshire Invention
FR2763853B1 (fr) * 1997-05-28 2000-01-07 Oreal Association d'un retinoide avec un polymere polyamine
WO2004018001A1 (en) 2002-08-22 2004-03-04 Dionysios Papaioannou Polyamine conjugates with acidic retinoids and preparation thereof

Also Published As

Publication number Publication date
ATE449613T1 (de) 2009-12-15
PT1569694E (pt) 2010-02-23
US20060189696A1 (en) 2006-08-24
CY1110285T1 (el) 2015-01-14
EP1569694B1 (en) 2009-11-25
WO2004018001A1 (en) 2004-03-04
ES2336772T3 (es) 2010-04-16
EP1569694A1 (en) 2005-09-07
AU2002324242A1 (en) 2004-03-11
US7517913B2 (en) 2009-04-14
DE60234542D1 (de) 2010-01-07

Similar Documents

Publication Publication Date Title
CY1110285T1 (el) Συζευγματα πολυαμινων με οξινα ρετινοειδη και παρασκευες τους
CR7894A (es) Conjugados polimericos de interferon-beta con potencia biologica aumentada
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
SG148192A1 (en) Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
NO20074037L (no) Farmasoytiske formuleringer med vedvarende frigivelse
BRPI0514731A (pt) derivados de pirimidina
ATE509951T1 (de) Humanes interferon-beta-mutein
WO2005003172A3 (en) Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
WO2007021839A3 (en) Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
NO20082376L (no) Farmasoytiske sammensetninger
ECSP066822A (es) Macrólidos y métodos para producir los mismos
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
UY28312A1 (es) Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
MXPA06002349A (es) Derivados de aminopropanol.
NO20090458L (no) Sukkerfrie, lagringsstabile antihistaminsaftpreparater
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
NO20053588L (no) Acylaminotiazol-derivater, fremstilling og anvendelse derav som beta-amyloidpeptid-produksjonsinhibitorer.
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
SE0300457D0 (sv) Novel compounds
GEP20074075B (en) Indazolamides with analgesic activity
AU2003293579A1 (en) Cyclohexane derivatives and methods for their preparation
NO20064858L (no) Nye assosiasjon mellom en heterosyklisk forbindelse og et antioksidantmiddel, og farmasoytiske sammensetninger inneholdende dem